Filing Details
- Accession Number:
- 0000874716-25-000088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-13 17:00:17
- Reporting Period:
- 2025-05-09
- Filing Date:
- 2025-05-13
- Accepted Time:
- 2025-05-13 17:00:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1442078 | V. Sophie Vandebroek | One Idexx Drive Westbrook ME 04092 | Yes | No | No | No |
Transaction Summary
| Sold: | 1,279 shares | Avg. Price: $491.34 | Total Value: $628,425.27 |
| Number of Shares After Transactions: | 1,167 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-09 | 1,279 | $283.59 | 2,446 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-05-09 | 1,279 | $491.34 | 1,167 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2025-05-09 | 1,279 | $0.00 | 1,279 | $283.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2030-05-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 8,173 | Indirect | By Sophie V. Vandebroek Revocable Trust |
Footnotes
- Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event was earlier.
- Not applicable.
Billionaire Hedge Funds
